Although there are several inconsistent reports, likely due to a variety of pathological stages of AD, different sample size, and condition of post-mortem brain tissue, the recent meta-analysis covering 98 articles supports the downregulation of the BDNF in blood, CSF, hippocampus, and cortex in AD patients [30]. The gene discussed is BDNF; the disease is Alzheimer disease.